The endothelium in clinical practice : source and target of novel therapies
Author(s)
Bibliographic Information
The endothelium in clinical practice : source and target of novel therapies
(Fundamental and clinical cardiology, v. 29)
M. Dekker, c1997
Available at 2 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Highlighting the transition from basic research to clinical applications, this unique reference presents the endothelium as both the source and the target of novel therapeutic concepts and discusses the involvement of the endothelium in mainstream approaches to the treatment of various conditions.
Table of Contents
The Endothelium as the Source of Novel Therapies
Prostacyclin (Prostaglandin I2) and Atherosclerosis, Karsten Schroer
Prostacyclin and Thromboxane: Role in Ischemic Heart Disease, Jawahar L. Mehta and Baichun C. Yang
Clinical Use of Prostacyclins, John A. Dormandy and Glyn Belcher
Nitric Oxide Synthases: Enzymology and Mechanism-Based Inhibitors, John F. Parkinson and Gary Phillips
Endothelin: From Basic to Pathophysiological Research, Katsutoshi Goto
Transmigration of Leukocytes, B. Stein, Y. Khew-Goodall, J. Gamble, and M. A. Vadas
Transforming Growth Factor-b and Cardiovascular Protection, David J. Grainger and James C. Metcalfe
Coagulation Factors, Michael Kalafatis, Jack O. Egan, and Kenneth G. Mann
The Endothelium as a Target for Novel Therapies
Endothelial Dysfunction and Vascular Disease, Paul M. Vanhoutte, Louis Perrault, and Jean Paul Vilaine
Complement and Endothelium: Novel Complement-Inhibitory Therapeutics, Una S. Ryan
The Receptor for Advanced Gycation Endproducts: Implications for the, Development of Diabetic Vascular Disease, Osamu Hori, Shi Du Yan, and Ann Marie Schmidt
Hypertension, Pierre Moreau and Thomas F. Luscher
Arterial Restenosis, Michael A. Reidy and Stephen M. Schwartz
Pathobiology and Clinical Consequences of Plaque Rupture, Richard Gallo, Juan J. Badimon, James H. Chesebro, Valentin Fuster, and Lina Badimon
Isoprostanes and Antioxidant Therapy in Human Diseases, Emma A. Meagher and Garrett A. FitzGerald
Vasculoprotection by Estrogen Contributes to Gender Difference in Cardiovascular Diseases: Potential Mechanism and Role of Endothelium, Katalin Kauser and Gabor M. Rubanyi
Lipoprotein(a): Insights from Transgenic Mice, Steven D. Hughes and Edward M. Rubin
Gene Therapy
Gene Therapy with Vascular Endothelial Growth Factor, Jeffrey M. Isner
Vascular Disease and the Prospect of Gene Therapy, Heiko E. von der Leyen and Victor J. Dzau
by "Nielsen BookData"